Adamant Biomedical Investments’s IMS HEALTH HLDGS INC COM STK (DE) IMS Stock Holding History

Adamant Biomedical Investments’s Portfolio IMS Stock Details IMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$256K	Buy	+10,000	New	+$252K	0.06%	96

Other funds holding IMS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Axon Capital New York $69.3M AUM

Adamant Biomedical Investments's IMS Position: Q4 2014 in Review

Adamant Biomedical Investments opened a new position in IMS HEALTH HLDGS INC COM STK (DE) (IMS) in Q4 2014: 10,000 shares worth $256K. The stake represents 0.06% of the portfolio and ranks #96 among its holdings.

105 funds tracked by Wall St. Rank hold IMS as of Q4 2014.

Adamant Biomedical Investments held 10,000 shares of IMS HEALTH HLDGS INC COM STK (DE) worth $256K as of Q4 2014.
IMS HEALTH HLDGS INC COM STK (DE) was a new Adamant Biomedical Investments position in Q4 2014.
IMS HEALTH HLDGS INC COM STK (DE) made up 0.06% of Adamant Biomedical Investments's portfolio in Q4 2014, its #96 holding.
105 funds tracked by Wall St. Rank held IMS HEALTH HLDGS INC COM STK (DE) as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.